Home
Storia in 4 fonti
Kimberly-Clark swoops on Tylenol maker Kenvue as US deal spree accelerates
$49bn tie-up comes on frantic day of mergers and acquisitions across corporate America
- ·
cnbc.com
Kimberly-Clark to buy Kenvue in $48.7 billion deal
Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.
- ·
Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.
- ·
bbc.com
Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal
The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.
- ·
ft.com
Kimberly-Clark swoops on Tylenol maker Kenvue as US deal spree accelerates
$49bn tie-up comes on frantic day of mergers and acquisitions across corporate America
- ·
aljazeera.com
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
- ·
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.